Reduced plasma phosphatidylethanolamines in e-cigarette, or vaping, product use-associated lung injury (EVaLI).
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of The User
McGraw (2022)
US adults’ Perceptions about the harms of Nicotine in Electronic Vapor Products on the adolescent Brain, United States, 2016-2017.
Population Clinical
Perception Of Risk
McGruder (2020)
high-Performance Liquid Chromatography-Tandem Mass Spectrometry analysis of Carbonyl Emissions from E-Cigarette, or Vaping, Products.
Nonclinical
Chemical
Methods
McGuigan (2022)
Factors that influence cannabis vaping habits of college students: a qualitative study.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
McKenzie (2022)
anxiety Sensitivity and Emotion Dysregulation in Dual and Exclusive E-Cigarette Users.
Individual Clinical
Safety
Adverse Effects
McLeish (2021)
Differences in young adults’ perceptions of e-cigarettes by history of use.
Population Clinical
Perceptions Of Risk
McLeish (2022)
E-Cigarette Use and Future Cigarette Initiation among Never Smokers and Relapse among Former Smokers in the PaTh Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
McMillen (2019)
Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and acrolein
Individual Clinical
Biomarkers
Biomarkers Of Exposure
McRobbie (2015)
E-cigarette palatability in smokers as a function of flavorings, nicotine content and propylthiouracil (PROP) taster phenotype.
Population Clinical
Likelihood Of Use
Former Smokers Initiating Use Of ENDS
Mead (2019)